SK바이오사이언스: management transactions · South Korea · DART (FSS) DART:sk-f4f047 KR KR · DART (FSS)
Browse the full directors' dealings record of SK바이오사이언스, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). The latest transaction was disclosed on 8 April 2021 (Purchase). Among the most active insiders: 김훈. Every trade is openly available.
Last declaration on 8 April 2021
Declarations 14 total
Executives ● Purchase0 DART
DART:20210408002026 · 8 Apr 2021
Ideal exit: 3 Jan 2022 (T+270) Executives ● Purchase0 DART
DART:20210408001996 · 8 Apr 2021
Ideal exit: 3 Jan 2022 (T+270) Executives ● Purchase0 DART
DART:20210408001983 · 8 Apr 2021
Ideal exit: 3 Jan 2022 (T+270) Executives ● Purchase0 DART
DART:20210408001963 · 8 Apr 2021
Ideal exit: 3 Jan 2022 (T+270) Executives ● Purchase0 DART
DART:20210408001940 · 8 Apr 2021
Ideal exit: 3 Jan 2022 (T+270) Executives ● Purchase0 DART
DART:20210325000705 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Purchase0 DART
DART:20210325000724 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Purchase0 DART
DART:20210325000730 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Purchase0 DART
DART:20210325000726 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Sale0 DART
377,684 shares
DART:20210325000757 · 25 Mar 2021
Executives ● Purchase0 DART
DART:20210325000769 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Purchase0 DART
DART:20210325000710 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Purchase0 DART
DART:20210325000718 · 25 Mar 2021
Ideal exit: 20 Dec 2021 (T+270) Executives ● Sale0 DART
377,684 shares
DART:20210325000702 · 25 Mar 2021
